Hyaluronic Acid Viscosupplementation Market By Product Type (Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis, Ankle Osteoarthritis and Others), Treatment Type (Single-Injection, Two-Injection, Three-Injection, Five-Injection), Dosage Form (Solution, Gel) By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres), and Geography

 

The global hyaluronic acid viscosupplementation market is expected to reach at US$ 4539.81 million in market and growing at a CAGR of 6.1% over the forecast period by 2028. The key drivers are considered to be increase in number of people with osteoarthritis, obese population due to the change in lifestyle and geriatric population contributing towards the growth of global hyaluronic acid viscosupplementation market. The key challenges include lack of safety and efficacy and complex regulatory process because reimbursement policies of different countries are independent of each other there are a considerable number of pipeline drugs waiting for approval. Demand for non-surgical method and high lifestyle related diseases open up a huge market for global market. Osteoarthritis is treated using a method called viscosupplementation. Because there is no treatment for arthritis, viscosupplementation is used to help the condition better. It is a viscous fluid called hyaluronate that is injected into the body to help support the synovial fluid's lubricating characteristics. As a result, it lessens the discomfort associated with osteoarthritis of the knee, improves mobility, and provides a more comfortable level of exercise. This is only utilised when other treatment options have been exhausted and failed to help with the management. The market is fueled by major factors such as an increase in the number of individuals suffering from osteoarthritis, which is expected to move the industry forward. The market is expected to grow throughout the projected period as people become more aware of the new treatments available for osteoarthritis management.